pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Preclinical
ulodesine
ulodesine
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Helix BioPharma Corp
Phase 3
ulotaront hydrochloride
ulotaront hydrochloride
Generalized Anxiety Disorder (GAD)
Otsuka Pharmaceutical Co Ltd
Phase 3
ulviprubart
ulviprubart
Inclusion Body Myositis (IBM)
Abcuro Inc
Marketed
← prev
page 226 of 231
next →
Pain
89
Neurology
1
umeclidinium bromide
Incruse Ellipta (umeclidinium bromide)
Chronic Bronchitis
GlaxoSmithKline LLC
Phase 2
umitrelimorgene autodencel
umitrelimorgene autodencel [INN]
Glioblastoma Multiforme (GBM)
Immunomic Therapeutics Inc
Phase 2
unasnemab
unasnemab
Traumatic Spinal Cord Injury
Tanabe Pharma Corp
Phase 3
upacicalcet sodium
upacicalcet sodium
Secondary Hyperparathyroidism
Pathalys Pharma Inc
Phase 2
urcosimod
urcosimod
Keratoconjunctivitis Sicca (Dry Eye)
$OKYO
OKYO Pharma Ltd
Marketed
uridine triacetate
Xuriden (uridine triacetate)
Mitochondrial Diseases
BTG International Inc
Marketed
urofollitropin
Bravelle (urofollitropin)
Anovulation
Ferring Pharmaceuticals Inc
Phase 1
usmarapride
usmarapride [INN]
Alzheimer's Disease
Suven Life Sciences Ltd
Phase 2
usnoflast
usnoflast
Amyotrophic Lateral Sclerosis
Zydus Lifesciences Ltd
Phase 2
utenpanium chloride
utenpanium chloride
Obesity
Raziel Therapeutics
Phase 2
utidelone
utidelone [INN]
Breast Cancer
BioStar Pharmaceuticals Inc
Phase 2
uzatresgene autoleucel
uzatresgene autoleucel
Ovarian Cancer
US WorldMeds LLC
Phase 2
vabametkib
vabametkib [INN]
Non-Small Cell Lung Cancer
Abion Inc
Phase 3
vactosertib
vactosertib [INN]
Metastatic Colorectal Cancer
MedPacto Inc
Phase 2
vadernersen sodium
vadernersen sodium
X Chromosome Disorders
$IONS
IONIS PHARMACEUTICALS INC
Phase 2
vafidemstat
vafidemstat [INN]
Borderline Personality Disorder (BPD)
Oryzon Genomics SA
Marketed
valbenazine
Valbenazine
Tardive Dyskinesia
Lupin Ltd
Phase 2
valemetostat
valemetostat [INN]
Non-Small Cell Lung Cancer
Daiichi Sankyo Co Ltd
Phase 1
valiloxybate ER
valiloxybate
Narcolepsy
$ALKS
Alkermes plc.
Phase 3
valiltramiprosate
valiltramiprosate
Alzheimer's Disease
Alzheon Inc
Marketed
valoctocogene roxaparvovec
Roctavian (valoctocogene roxaparvovec)
Hemophilia A (Factor VIII Deficiency)
$BMRN
BIOMARIN PHARMACEUTICAL INC
Marketed
valrubicin
Valstar (valrubicin)
Bladder Carcinoma
Endo Pharmaceuticals Inc
Marketed
valsartan
Valsartan
Cardiovascular Risk Factors
Square Pharmaceuticals PLC
Phase 3
vamikibart
vamikibart
Panuveitis
F. Hoffmann-La Roche Ltd
Marketed
vamorolone
Agamree (vamorolone)
Becker Muscular Dystrophy
ReveraGen BioPharma Inc
Phase 2
vamotinib
vamotinib [INN]
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Fusion Pharmaceuticals Inc
Marketed
vancomycin hydrochloride
Vancomycin Hydrochloride
Bacterial Endocarditis
Samson Medical Technologies LLC
